Table 2

Ischaemia from baseline to post-treatment based on treatment modality

Overall cohortMedical therapyRevascularisationp Value*
Baseline SSS
 Mean±SD13±713±715±60.015
 Median (Q1, Q3)14 (9, 18)13 (8, 17)15 (12, 19)
Baseline SRS
 Mean10±610±610±60.325
 Median10 (5, 14)10 (5, 15)8 (5, 13)
Baseline ischaemia (%LV) calculated from SDS
 Mean9±127±1115±12<0.001
 Median5 (0, 14)0 (0, 11)13 (5, 22)
Post-treatment SSS
 Mean14±714±814±70.757
 Median14 (9, 20)14 (9, 20)14 (9, 20)
Post-treatment SRS
 Mean12±713±711±70.094
 Median12 (7, 18)12 (7, 18)11 (6, 16)
Post-treatment ischaemia (%LV) from SDS
 Mean6±105±98±120.004
 Median0 (0, 8)0 (0, 7)4 (1, 13)
Change in ischaemia (%LV) from SDS
 Mean−3±12−2±12−6±12<0.001
 Median0 (−8, 1)0 (−6, 2)−6 (−12, 0)
  • Represented as mean (±SD) and median (Q1, Q3).

  • *p Value represents comparison of medical therapy and revascularisation groups.

  • LV, left ventricle; SDS, summed difference score; SSS, summed stress score.